Designing peptide amphiphiles as novel antibacterials and antibiotic adjuvants against gram-negative bacteria
Bioorganic & Medicinal Chemistry · 2023
DOI: 10.1016/j.bmc.2023.117481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2023. Verfasst von Huihua Xing und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, United States. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Gram-Negative Bacteria, Drug Design, Antimicrobial Cationic Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Gram-negative strains are intrinsically resistant to most antibiotics due to the robust and impermeable characteristic of their outer membrane. Self-assembling cationic peptide amphiphiles (PAs) have the ability to disrupt bacteria membranes, constituting an excellent antibacterial alternative to small molecule drugs that can be used alone or as antibiotic adjuvants to overcome bacteria resistance. PA1 (C16KHKHK), self-assembled into micelles, which exhibited low antibacterial activity against all strains tested, and showed strong synergistic antibacterial activity in combination with Vancomycin with a Fractional Inhibitory Concentration index (FICi) of 0.15 against E. coli. The molecules, PA2 (C16KRKR) and PA3 (C16AAAKRKR), also self-assembled into micelles, displayed a broad-spectrum antibacterial activity against all strains tested, and low susceptibility to resistance development over 21 days. Finally, PA1, PA 2 and PA3 displayed low cytotoxicity against mammalian cells, and PA2 showed a potent antibacterial activity and low toxicity in preliminary in vivo models using G. mellonella. The results show that PAs are a great platform for the future development of effective antibiotics to slow down the antibiotic resistance and can act as antibiotic adjuvants with synergistic mechanism of action, which can be repurposed for use with existing antibiotics commonly used to treat gram-positive bacteria to treat infections caused by gram-negative bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, United States.
- Department of Chemistry, University of Nebraska Omaha, Omaha, NE 68182, United States.
- Department of Biology, University of Nebraska Omaha, Omaha, NE 68182, United States.
- Department of Chemistry, University of Nebraska Omaha, Omaha, NE 68182, United States. Electronic address: nalmeida@trinity.edu.
Förderung
- National Science Foundation
Zitieren
APA
Xing, H., Loya-Perez, V., Franzen, J., Denton, P. W., Conda-Sheridan, M., & Rodrigues de Almeida, N. (2023). Designing peptide amphiphiles as novel antibacterials and antibiotic adjuvants against gram-negative bacteria. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2023.117481
Vancouver
Xing H, Loya-Perez V, Franzen J, Denton PW, Conda-Sheridan M, Rodrigues de Almeida N. Designing peptide amphiphiles as novel antibacterials and antibiotic adjuvants against gram-negative bacteria. Bioorganic & Medicinal Chemistry. 2023. doi:10.1016/j.bmc.2023.117481
BibTeX
@article{Xing2023,
author = {Xing, Huihua and Loya-Perez, Vanessa and Franzen, Joshua and Denton, Paul W and Conda-Sheridan, Martin and Rodrigues de Almeida, Nathalia},
title = {Designing peptide amphiphiles as novel antibacterials and antibiotic adjuvants against gram-negative bacteria},
journal = {Bioorganic & Medicinal Chemistry},
year = {2023},
doi = {10.1016/j.bmc.2023.117481}
}
EUVIMED